Literature DB >> 29517630

Impact of Antibiotic-Resistant Bacterial and Fungal Infections in Outcome of Acute Pancreatitis.

Praneeth Moka, Pooja Goswami, Arti Kapil, Immaculata Xess, Vishnubhatla Sreenivas, Anoop Saraya.   

Abstract

OBJECTIVES: The knowledge about pathogens and their antibiotic susceptibility patterns is essential to select an appropriate antibiotic.
METHODS: We investigated the microbiological profile in pancreatic and extrapancreatic infections, and antibiotic sensitivity pattern in patients with acute pancreatitis.
RESULTS: Of 556 patients with acute pancreatitis, only 189 developed bacterial infection; however, bacteremia was present in 42 patients (7.6%). Culture-proven infected pancreatic necrotic collection was present in 161 patients (29%). Escherichia coli and Klebsiella pneumoniae were the most common organisms. Among the bacterial infection cohort, 164 patients developed multidrug-resistant bacterial infection. Infection with multidrug-resistant bacteria, especially at multiple sites, increased mortality. Nearly 50% of patients (n = 94) acquired extremely drug-resistant bacterial infection at some time and emerged as key reason for prolonged hospital and intensive care unit stay. Colistin resistance and tigecycline resistance were documented in 2.1% and 17.2% of the specimens at admission and in 4.6% and 21% of specimens during the hospital stay. Of 556 patients, 102 patients developed fungal infection and 28 patients had only fungal infection without bacterial infection.
CONCLUSIONS: Colistin and tigecycline are best reserved as last-resort antibiotics. Fungal infection was found to be associated with increased mortality, median hospital stay, and intensive care unit stay.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29517630     DOI: 10.1097/MPA.0000000000001019

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

1.  Timing, distribution, and microbiology of infectious complications after necrotizing pancreatitis.

Authors:  Jiong-Di Lu; Feng Cao; Yi-Xuan Ding; Yu-Duo Wu; Yu-Lin Guo; Fei Li
Journal:  World J Gastroenterol       Date:  2019-09-14       Impact factor: 5.742

2.  Epidemiology and prognosis of anti-infective therapy in the ICU setting during acute pancreatitis: a cohort study.

Authors:  Philippe Montravers; Elie Kantor; Jean-Michel Constantin; Jean-Yves Lefrant; Thomas Lescot; Nicolas Nesseler; Catherine Paugam; Matthieu Jabaudon; Hervé Dupont
Journal:  Crit Care       Date:  2019-12-05       Impact factor: 9.097

3.  Risk Factors of Multidrug Resistant Pathogens Induced Infection in Severe Acute Pancreatitis.

Authors:  Xina Li; Le Li; Lu Liu; Yingying Hu; Shuang Zhao; Jialiang Sun; Gang Wang; Xin Hai
Journal:  Shock       Date:  2020-03       Impact factor: 3.533

Review 4.  Application of nanotechnology in the diagnosis and treatment of acute pancreatitis.

Authors:  WeiLu Jia; LinFeng Xu; WenJing Xu; Meng Yang; YeWei Zhang
Journal:  Nanoscale Adv       Date:  2022-03-19

5.  Infected Pancreatic Necrosis due to Multidrug-Resistant Organisms and Persistent Organ failure Predict Mortality in Acute Pancreatitis.

Authors:  Saransh Jain; Soumya Jagannath Mahapatra; Swatantra Gupta; Pramod Kumar Garg
Journal:  Clin Transl Gastroenterol       Date:  2018-10-05       Impact factor: 4.488

6.  Impact of prior antibiotics on infected pancreatic necrosis microbiology in ICU patients: a retrospective cohort study.

Authors:  Charlotte Garret; Emmanuel Canet; Stéphane Corvec; David Boutoille; Matthieu Péron; Isabelle Archambeaud; Aurélie Le Thuaut; Jean-Baptiste Lascarrou; Frédéric Douane; Marc Lerhun; Nicolas Regenet; Emmanuel Coron; Jean Reignier
Journal:  Ann Intensive Care       Date:  2020-06-15       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.